The Telstra-backed provider of commercial insurance and broker software has reached $162m of total funding through its latest round.

Tencent and Taikang Insurance Group co-led the asset data software producer's latest round with Citic Private Equity Funds Management.

Lilly Asia Ventures took part in a $78m round for oncology therapy developer BH Med while gifting platform developer Snappy completed a $70m Hearst-backed series C.

Alexandria Venture Investments has participated in an $88.9m round which has pushed the biotech developer's total funding past $142m.

Lilly Asia Ventures has returned to back the immuno-oncology therapy developer’s latest round, eight months after participating in the company’s series B.

Asahi Kasei, GlaxoSmithKline and Johnson & Johnson helped the respiratory disease drug developer boost its overall funding to $150m.

GV has returned to back the indoor farming operator’s series C round at a $2.3bn valuation, helping to take its total funding to over $470m.

Exor-backed card issuing technology provider Lithic raised $43m while Mitsui Sumitomo Insurance is providing $36m to lead Upstream Security's series C round.

BioTheryX, Immuta and Pitch are among the companies that have raised fresh capital from corporates such as Intel Capital, Slack Fund, Citi Ventures and Dell Technologies Capital.

Slack-backed Loom has completed a $130m series C round led by Andreessen Horowitz.